40 reports of this reaction
1.9% of all CARBOPROST TROMETHAMINE reports
#11 most reported adverse reaction
PALPITATIONS is the #11 most commonly reported adverse reaction for CARBOPROST TROMETHAMINE, manufactured by Pharmacia & Upjohn Company LLC. There are 40 FDA adverse event reports linking CARBOPROST TROMETHAMINE to PALPITATIONS. This represents approximately 1.9% of all 2,057 adverse event reports for this drug.
Patients taking CARBOPROST TROMETHAMINE who experience palpitations should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PALPITATIONS is a less commonly reported adverse event for CARBOPROST TROMETHAMINE, but still significant enough to appear in the safety profile.
In addition to palpitations, the following adverse reactions have been reported for CARBOPROST TROMETHAMINE:
The following drugs have also been linked to palpitations in FDA adverse event reports:
PALPITATIONS has been reported as an adverse event in 40 FDA reports for CARBOPROST TROMETHAMINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
PALPITATIONS accounts for approximately 1.9% of all adverse event reports for CARBOPROST TROMETHAMINE, making it a notable side effect.
If you experience palpitations while taking CARBOPROST TROMETHAMINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.